Skip to content

Evidence-based Intervention for Diabetes Prevention

Evidence-based Intervention for Diabetes Prevention

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07443995
Acronym
EID
Enrollment
30
Registered
2026-03-02
Start date
2026-04-01
Completion date
2027-08-01
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diet Prevention of Metabolic Diseases, Lifestyle Risk Reduction, Pre-diabetes

Keywords

pre-diabetes, behavioral intervention, diet, physical activity

Brief summary

The goal of this behavioral intervention trial is to develop strategies to decrease the incidence of diabetes within the UAE. The investigators will investigate the effectiveness of a group-based telehealth intervention facilitated by a health coach in adults at risk for developing diabetes who live in the UAE. The investigators will conduct a single-arm feasibility trial of the Evidence-based Intervention for Diabetes prevention among thirty adults with prediabetes. All participants will receive 12 weekly virtual intervention sessions over the course of three months, facilitated by a trained DPP lifestyle coach who is from the same cultural community and can deliver the material in either Arabic or English. The primary feasibility measure is acceptability, as measured by intervention session attendance. Other outcome assessments will be conducted at baseline and three months at NYU Abu Dhabi, where study staff will assess weight, hemoglobin A1c, diet, and physical activity.

Detailed description

Study Purpose This feasibility study will investigate the effectiveness of an individual automated plus group-based telehealth arm facilitated by a health coach. The long-term goal is to develop strategies to decrease the incidence of diabetes within the UAE. Study Hypotheses Participants will attend \>50% of intervention sessions and will experience a clinically significant reduction in weight of 3.5% after 12 weeks. Predictors of intervention acceptability will include age, gender, and baseline body mass index. Study Objectives Study investigators will conduct a single-arm feasibility trial of the Evidence-based Intervention for Diabetes prevention among thirty adults with prediabetes. All participants will receive 12 weekly virtual intervention sessions over the course of three months, facilitated by a trained DPP lifestyle coach who is from the same cultural community and can deliver the material in either Arabic or English. The primary feasibility measure is acceptability. Other outcome assessments will be conducted at baseline and three months at NYU Abu Dhabi where study staff will assess weight, hemoglobin A1c, diet, and physical activity. This project will accomplish the following specific aims: Aim 1: Identify predictors associated with intervention adherence. Predictors of adherence to intervention arms will include age, gender, and baseline body mass index. Predictors of adherence to intervention arms will include age, gender, and baseline body mass index. Investigators will also evaluate the acceptability of the intervention using surveys and semi-structured interviews. Aim 2: Assess the effectiveness of the intervention on key clinical outcomes. Hypothesis 2: Participants will experience a clinically significant reduction in weight of 3.5% after 12 weeks. In-person outcome assessment visits to measure weight and glycemia at baseline, and 3 months among all participants will be conducted.

Interventions

The intervention is based on the CDC Diabetes Prevention Program and has been adapted into a culturally appropriate intervention in an Arab context. The program has been condensed into 12 sessions with an additional session that addresses lifestyle factors during Ramadan. Each session covers a different topic related to diet, physical activity, sleep, and stress management. Additionally, the intervention includes written materials to help participants develop lifestyle goals and encourages them to seek social support. There are a series of 12 videos in Arabic and English that support the information delivered in the group sessions. In addition to the group sessions, participants will have access to the automated app and education materials.

BEHAVIORALApp based support

This intervention will provide educational videos that have been culturally adapted to the Arab context and additional automated supports for lifestyle modification. Study participants will be provided with access to an app that they will be encouraged to engage with on a regular basis. The app will provide basic diet, physical activity, and lifestyle support to prevent diabetes. Participants will also be able to track activity, diet, and receive feedback on their personal weight, diet habits, and activity levels.

Participants will be provided written or web-based diabetes prevention materials. These materials will provide basic tips on diet, physical activity and other lifestyle factors.

Sponsors

New York University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and women 18 years or older * Diabetes risk score \> 5 * BMI \>=25kg/m\^2 * Arabic or English speaking * Able to read and write in Arabic or English * Access to a smartphone * Provide informed consent

Exclusion criteria

* Prevalent diabetes * Prior participation in a diabetes prevention program * Taking FDA-approved weight loss medications * Pregnant or lactating

Design outcomes

Primary

MeasureTime frameDescription
Intervention acceptability based on the proportion of sessions attended3 months (post intervention)Acceptability of the intervention will be measured by the number (%) of intervention sessions attended. Each participant will be offered 12 intervention sessions, and the acceptability of the intervention will be measured by the proportion of sessions attended (# sessions attended/ 12).

Secondary

MeasureTime frameDescription
Changes in glycemia0 and 3 monthsChanges in HbA1c at 3 months post baseline.

Countries

United Arab Emirates

Contacts

CONTACTJeannette Beasley, PhD
jbeasley@nyu.edu646-501-4681
PRINCIPAL_INVESTIGATORJeannette Beasley, PhD

New York University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026